Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgery

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

(2010) Kelly-Anne Phillips et al.   BREAST

Cognitive function after adjuvant treatment for early breast cancer: a population-based longitudinal study

(2010) Jeanne Debess et al.   BREAST CANCER RESEARCH AND TREATMENT

Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial

(2010) Christina M. Schilder et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Incidence and Incidence Rates in Japan in 2003: Based on Data from 13 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project

(2009) T. Matsuda et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Longitudinal change of treatment-related upper limb dysfunction and its impact on late dysfunction in breast cancer survivors: A prospective cohort study

(2009) Eun Joo Yang et al.   JOURNAL OF SURGICAL ONCOLOGY

Changes in quality of life among breast cancer patients three years post-diagnosis

(2008) Wei Lu et al.   BREAST CANCER RESEARCH AND TREATMENT

The relationship between overall quality of life and its subdimensions was influenced by culture: analysis of an international database

(2008) Neil W. Scott et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls

(2008) Jaime L. Palmer et al.   Journal of Cancer Survivorship